We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Avastin Study Results Could Change Prescribing for Cervical Cancer
NIH Avastin Study Results Could Change Prescribing for Cervical Cancer
February 8, 2013
Adding Genentech’s Avastin to chemotherapy extends the life of cervical cancer patients compared with chemotherapy alone, an NIH-sponsored study finds.